Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2025.12.15

Pushing Boundaries in Organic Chemistry: IISc Prof. Santanu Mukherjee at Sai Life Sciences

As part of Sai Life Sciences’ ongoing initiative to foster meaningful scientific engagement through interactions with distinguished researchers, Prof. Santanu Mukherjee, Professor in the Department of Organic Chemistry at IISc Bangalore, visited our Integrated R&D campus for a full-day programme of knowledge exchange.

He delivered an insightful masterclass on his group’s work in enantioselective desymmetrization—a powerful strategy for rapidly building molecular complexity and enabling the formation of multiple stereocenters in a single step. The session highlighted organocatalytic desymmetrization reactions developed in his laboratory, including formal C(sp²)–H alkylation and the de novo construction of (hetero)arenes, and their application in the enantioselective synthesis of [3]-ladderanol, [5]-ladderanoic acid, and related analogues. He also discussed recent advances using alkoxy-directed dienamine catalysis for generating unnatural benzo-analogues of ladderanol.

In addition to the masterclass, Prof. Mukherjee joined Dr. Santosh Kulkarni for an engaging Fireside Chat with our scientific community. From the importance of documenting every detail in the lab to the question of what it will take for an Indian chemist to win the Nobel Prize, the conversation offered a candid exploration of the discipline, ambition, and ecosystem needed to push science forward. He reflected on global shifts shaping organic chemistry, the realities of research culture, and why rigor often matters more than brilliance.

Dr. Santanu Mukherjee, one of the country’s leading organic chemists and a global expert in asymmetric catalysis. After research stints in Germany and the US, including Harvard University, he returned to IISc Bangalore to build a laboratory that is now known for breakthrough enantioselective transformations and innovative catalytic approaches. With numerous recognitions and editorial appointments, he continues to shape the direction of contemporary organic chemistry.

Share article

More News

2026.02.06

Sai Life Sciences Limited delivers robust performance in 9MFY26

Revenue up by 43%; EBITDA up by 79%; Net Profit up by 199% Hyderabad, February 05, 2026: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), one of India’s fastest growing Contract Research, Development and Manufacturing Organizations (CRDMO) announced its financial results for the third quarter and nine months ended December 2025. Financial Performance: Particulars […]
Read more

2026.01.28

Mabtech and Sai Life Sciences Announce Strategic Collaboration to Advance Immunology Research with EYRA Platform at Sai Boston Site

Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated Contract Research, Development, and Manufacturing Organization (CRDMO), today announced a strategic collaboration that establishes Sai’s Boston laboratory as a co-marketed US execution and demonstration hub for the Mabtech EYRA™ platform. Under this collaboration, Mabtech and Sai will […]
Read more

2026.01.12

Sai Life Sciences laboratories achieve Green Lab Certification

Sai Life Sciences has achieved Green Lab Certification for two PR&D laboratories and two Medicinal Chemistry laboratories under the My Green Lab (MGL) framework, with a compliance score of over 98%.The certification reflects the company’s systematic efforts to integrate sustainability into daily laboratory operations, with measurable reductions in energy consumption, water usage, waste generation, and […]
Read more

2025.12.19

Sai Life Sciences Releases Sustainability Report 2025

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s fastest-growing Contract Research, Development, and Manufacturing Organizations (CRDMO), today announced the release of its Sustainability Report for 2024–25. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 and the Sustainability Accounting Standards Board (SASB) standards, this sixth edition is presented under the […]
Read more

2025.11.27

India is evolving from being a tactical supplier to a strategic partner to global pharma

Krishna Kanumuri, MD & CEO of Sai Life Sciences, was recently interviewed by Pharmaceutical Executive for its feature on next-generation CDMOs. In the interview, he shares insights on how Indian CDMOs are evolving from tactical suppliers to strategic partners, the shifting global supply-chain landscape, and how Sai Life Sciences is preparing for the opportunities and […]
Read more